• Publications
  • Influence
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
TLDR
The angiotensin-II-receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes, independent of the reduction in blood pressure it causes.
Association of a human G-protein β3 subunit variant with hypertension
TLDR
A novel polymorphism (C825T) in exon 10 of the gene encoding the p3 subunit of heterotrimeric G proteins (GNB3) is detected, which suggests a significant association of the T allele with essential hypertension.
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
TLDR
A multicenter, randomized, double-blind, prospective study of 1255 subjects with type 2 diabetes mellitus receiving maintenance hemodialysis who were randomly assigned to receive 20 mg of atorvastatin per day or matching placebo found the median level of low-density lipoprotein cholesterol was reduced.
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
TLDR
FGF23 is a novel independent predictor of progression of renal disease in patients with nondiabetic CKD after adjustment for age, gender, GFR, proteinuria, and serum levels of calcium, phosphate, and parathyroid hormone.
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
TLDR
The current state of knowledge and the implications for patient care in important topic areas, including coronary artery disease and myocardial infarction, congestive heart failure, cerebrovascular disease, atrial fibrillation, peripheral arterial disease, and sudden cardiac death are defined.
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
The Heidelberg classification of renal cell tumours
TLDR
This paper presents the conclusions of a workshop entitled ‘Impact of Molecular Genetics on the Classification of Renal Cell Tumours’, which was held in Heidelberg in October 1996 and is applicable to routine diagnostic practice.
Nephropathy in patients with type 2 diabetes mellitus.
  • E. Ritz, S. Orth
  • Medicine
    The New England journal of medicine
  • 7 October 1999
TLDR
Some recent and encouraging evidence indicates that diabetic nephropathy and deterioration of renal function are to a certain extent preventable.
...
1
2
3
4
5
...